Baxter Healthcare Corporation — FDA Facility Profile

FEI 1314492

Baxter Healthcare Corporation is an FDA-registered facility (FEI 1314492) located in MEDINA, NY, US. RegDataLab tracks 7 FDA inspections and 1 compliance action at this facility.

Reviewing Baxter Healthcare Corporation as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Baxter Healthcare Corporation yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

What FDA found at this site

Latest inspection
Apr 4, 2025: Voluntary Action Indicated (VAI)
Inspections on record
7 (4 VAI, 3 NAI)
Last OAI inspection
None on record
Warning letters
1 listed by FDA for this FEI, latest Apr 1, 2013
Recalls as the recalling firm
10, latest Mar 19, 2021

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Apr 4, 2025Voluntary Action Indicated (VAI)Lack of or inadequate complaint procedures (21 CFR 820.198(a))
Lack of or inadequate procedures (21 CFR 820.100(a))
Sep 28, 2021No Action Indicated (NAI)Design validation - software validation not performed (21 CFR 820.30(g))
Aug 21, 2017No Action Indicated (NAI)Lack of or inadequate receiving acceptance procedures (21 CFR 820.80(b))
Process control procedures, Lack of or inadequate procedures (21 CFR 820.70(a))
Lack of or inadequate process validation (21 CFR 820.75(a))
Aug 28, 2012Voluntary Action Indicated (VAI)Report of risk to health (21 CFR 806.10(a)(1))
Purchasing controls, Lack of or inadequate procedures (21 CFR 820.50)
Lack of or inadequate process validation (21 CFR 820.75(a))
Dec 8, 2010Voluntary Action Indicated (VAI)DHR content (21 CFR 820.184)
Training records (21 CFR 820.25(b))
Aug 31, 2010Voluntary Action Indicated (VAI)Lack of or inadequate procedures (21 CFR 820.100(a))
Documented evaluation (21 CFR 820.50(a)(1))
Process changes - review, evaluation and revalidation (21 CFR 820.75(c))
Time to report - 10 days (21 CFR 806.10(b))
and 1 more
Dec 22, 2009No Action Indicated (NAI)No citations listed

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Mar 19, 2021Class IIZ-1487-2021Spectrum IQ - Infusion Pump - Product Usage: intended to be used for the controlled…
Potentially defective component in the AC power adapter which may fail over time.
Jan 6, 2021Class IIZ-1150-2021Infusion Pump
Battery performance issues related to prolonged storage.
Sep 18, 2018Class IIZ-0107-2019SPECTRUM IQ INFUSION SYSTEM WITH DOSE IQ SAFETY SOFTWARE, 3570009
If an operator attempts to manually program a Basic Infusion for a drug that is not included in the Drug Library using the Basic-Dose Mode…
Jun 21, 2018Class IIZ-1248-2019Baxter SIGMA Spectrum Infusion Pump with Master Drug Library (Version 6), product code…
The flow rate test verification was not properly executed for certain Sigma Spectrum infusion pumps prior to release. The testing was…
May 8, 2018Class IIZ-2112-2018Baxter SIGMA Spectrum Infusion Pump with Master Drug Library (Version 6), infusion pump… and 1 more product
The firm will be updating the Instructions for Use for the product. Current IFUs instruct users to lower the primary bag 20 inches below the…
Apr 3, 2018Class IIZ-1663-2018Baxter Sigma Spectrum Infusion Pump with master Drug Library (Version 6)… and 4 more products
Service technician improperly documented final release testing on product, indicating that the full battery of release tests were performed…
Oct 6, 2017Class IIZ-0971-2018Baxter SIGMA Spectrum Infusion Pump with Master Drug Library (Version 6) (GTIN…
Certain infusion pumps may exhibit excessive wear of the pumping mechanism caused by a lack of lubrication, this could affect the occlusion…
Jan 26, 2017Class IIZ-1693-2017Baxter SIGMA Spectrum Infusion Pump with Master Drug Library, Model #/Product Code…
SIGMA Spectrum Infusion Pumps with Master Drug Library, Software V8.00.02 contains an anomaly that may cause a Sharp Watchdog Timeout…
Apr 23, 2012Class IIIZ-2030-2012SIGMASpectrum Infusion Pump Master Drug Library (MDL) Editor software. Product…
Sigma is a safety alert for the Master Drug Library (MDL) Editor software associated with the SIGMA Spectrum Infusion Pump System because it…
Jul 6, 2011Class IZ-1490-2012Sigma Spectrum VOLUMETRIC INFUSION PUMP, with or without Master Drug Library, Part Number…
Recall expansion; the infusion pumps have the potential to fail causing inaccurate flow conditions during use. These conditions range from…

Facility details

Company
Baxter Healthcare Corporation
Location
MEDINA, NY (US)
Source
device

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.